Glipizide Oral Tablet, Extended Release 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Glipizide: Oral tablet, extended release (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_1996.JPG
Glipizide 10mg ER Tab
Actavis Inc. formerly Watson Pharmaceuticals Inc
Pill Identification: WPI 845 
Drug Image file DrugItem_7978.JPG
Glipizide XL 10mg Tab
Greenstone Ltd
Pill Identification: GLIPIZIDE XL 10 

What is this Medicine?

GLIPIZIDE (GLIP i zide) helps to treat type 2 diabetes. It is combined with diet and exercise. The medicine helps your body to use insulin better.

CVS Pharmacy Patient Statistics for Glipizide: Oral tablet, extended release(10mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Glipizide 10mg Extended-Release Tablet

NDC: 005910845
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Type 2 Diabetes Mellitus

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Store in original container
Store in a dry place
Glipizide 10mg Extended-Release Tablet
Drug Image file DrugItem_1996.JPG
Actavis Inc. formerly Watson Pharmaceuticals Inc
Pill Identification: WPI 845 
Shape: round
Color: white

Reported Side Effects for Glipizide 10mg Extended-Release Tablet

Balance Problems Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
No White Blood Cells Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Cholestasis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Inflamed Blood Vessels Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Vomiting Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
Blurred Vision Incidence:
<3.0%*
Severity: MODERATE
Onset: EARLY
Confusion Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Flushing Incidence:
<0.1%*
Severity: MILD
Onset: RAPID
Hemolysis Incidence:
<0.1%*
Severity: MODERATE
Onset: EARLY
Liver Failure Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Excessive Mucle Tone Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Hypoesthesia Incidence:
<3.0%*
Severity: MILD
Onset: DELAYED
Decreased Sexual Desire Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Pancytopenia Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Paresthesias Incidence:
<3.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Angioedema Incidence:
<0.1%*
Severity: SEVERE
Onset: RAPID
Decreased Appetite Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
<3.0%*
Severity: MILD
Onset: DELAYED
Aplastic Anemia Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Joint Pain Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Gas Incidence:
<3.2%*
Severity: MILD
Onset: EARLY
Excessive Sweating Incidence:
<3.0%*
Severity: MILD
Onset: DELAYED
Low Blood Sodium Levels Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Hives Incidence:
<1.4%*
Severity: MILD
Onset: RAPID
Inability To Sleep Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
Shaking Incidence:
<3.6%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
<0.1%*
Severity: MILD
Onset: EARLY
Low Platelet Count Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
SIADH Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Heartburn Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
1.0-2.9%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
1.0-2.9%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
1.4-5.4%*
Severity: MILD
Onset: EARLY
Scaly And Itchy Rashes Incidence:
1.4%*
Severity: MODERATE
Onset: DELAYED
Rash With Pustules Incidence:
1.4%*
Severity: MILD
Onset: EARLY
Itching Incidence:
1.4-2.9%*
Severity: MILD
Onset: RAPID
Upset Stomach Incidence:
1.4-2.9%*
Severity: MILD
Onset: EARLY
Low Blood Sugar Incidence:
1.8-39.0%*
Severity: MODERATE
Onset: EARLY
Drowsiness Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
2.0-6.8%*
Severity: MILD
Onset: EARLY
Headache Incidence:
2.0-8.6%*
Severity: MILD
Onset: EARLY
Weight Gain Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Secondary Failure Incidence:
21.8-46.8%*
Severity: SEVERE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Glipizide 10mg Extended-Release Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Alcohol and Glipizide 10mg Extended-Release Tablet(Glipizide)
Alcohol and Sulfonylureas(Glipizide)
Alcohol may interfere with the actions of Antidiabetic agents (Insulin or other drugs used to treat Diabetes). Alcoholic beverages can increase the risk of low blood sugar, or can cause increased blood sugar due to the calories in these beverages. Limit alcohol containing medicines and beverages if you are on Antidiabetic Agents. You should also learn how to recognize the signs of low blood sugar.
Minor Lifestyle Interaction
Tobacco and Glipizide 10mg Extended-Release Tablet(Glipizide)
Tobacco and Sulfonylureas(Glipizide)
If you use tobacco or are trying to quit tobacco use, you may need to monitor your blood sugar more frequently. Nicotine, a component of tobacco, can increase the blood sugar. Also, if you are trying to quit smoking, as your body adjusts to not smoking, your blood sugar levels may change; the actions of Antidiabetic Agents (medicines used to treat diabetes) may be increased and this could lead to low blood sugar. Know the symptoms of low or high blood sugar and report them if they occur. Monitor your blood sugar regularly.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Glipizide

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.